(This story originally appeared in the July-August issue of MJBizMagazine.)
It hasn’t always been easy, but keeping faith in the European cannabis market is about to pay off for Niklas Kouparanis.
The Bloomwell Group founder and CEO first joined Germany’s medical cannabis industry in 2017 as sales and marketing director at Cannamedical Pharma in Köln before founding Frankfurt-based Farmako in 2018 and then exiting the company in 2019.
ADVERTISEMENT
Since launching Frankfurt-headquartered Bloomwell in 2020, Kouparanis has grown the company into one of Germany’s top medical marijuana businesses.
In that time, Germany’s medical cannabis market developed slowly, constricted by regulations that made patient access difficult while an adult-use marijuana market remained a distant dream.
That changed in April, after Germany – Europe’s biggest economy –
Read full article on Marijuana Business Daily
